Pmc Pharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 65.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 58.26 Cr
as on 24-10-2024
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 25.00 Cr
as on 24-10-2024
- Revenue -21.03%
(FY 2023)
- Profit -71.40%
(FY 2023)
- Ebitda -74.92%
(FY 2023)
- Net Worth -192.22%
(FY 2023)
- Total Assets -10.93%
(FY 2023)
About Pmc Pharmaceuticals India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 65.00 Cr and a paid-up capital of Rs 58.26 Cr.
The company has closed loans amounting to ₹25.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Pmc Pharmaceuticals India Private Limited India is Urvi Kanodia as COMPANY SECRETARY. Paritosh Chakrabarti, Koneru Kumar, Raj Chakrabarti, and One other member serve as directors at the Company.
- CIN/LLPIN
U24290WB2016FTC218270
- Company No.
218270
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
10 Nov 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Hooghly, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Pmc Pharmaceuticals India?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Koneru Kumar  | Managing Director | Current | |
| Urvi Kanodia | Company Secretary | 15-Jun-2022 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manmohan Kishore | Additional Director | 24-Jun-2019 | Current |
Paritosh Chakrabarti  | Director | 10-Nov-2016 | Current |
| Raj Chakrabarti | Director | 10-Nov-2016 | Current |
Financial Performance of Pmc Pharmaceuticals India.
Pmc Pharmaceuticals India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 21.03% decrease. The company also saw a substantial fall in profitability, with a 71.4% decrease in profit. The company's net worth observed a substantial decline by a decrease of 192.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pmc Pharmaceuticals India?
In 2023, Pmc Pharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pmc Rubber Chemicals India Private LimitedActive 19 years 1 monthParitosh Chakrabarti and Raj Chakrabarti are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 09 Nov 2017 | ₹25.00 Cr | Satisfied |
How Many Employees Work at Pmc Pharmaceuticals India?
Pmc Pharmaceuticals India has a workforce of 86 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pmc Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pmc Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
